SCHEMBL21376546

SCHEMBL21376546

CC(C)N(C(C)C)P(OCCC#N)OC1C2C[C@H](n3cnc4c(NC(=O)c5ccccc5)ncnc43)O[C@@H]21

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.39
P2RY12 Q9H244 8/20 0.37
ADORA1 P30542 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23898888 1.00 PRMT6 (0.39) PRMT6P2RY12ADORA1
SCHEMBL26455087 0.92 P2RY12 (0.36) PRMT6P2RY12
SCHEMBL25504694 0.89 ADORA1 (0.41) PRMT6ADORA1
SCHEMBL25505318 0.89 PRMT6 (0.39) PRMT6P2RY12ADORA1
SCHEMBL23547992 0.86 PRMT6 (0.40) PRMT6P2RY12ADORA1
SCHEMBL17589238 0.85 PRMT6 (0.42) PRMT6P2RY12ADORA1
SCHEMBL18521428 0.85 ADORA1 (0.43) PRMT6P2RY12ADORA1
SCHEMBL26435560 0.85 PRMT6 (0.41) PRMT6P2RY12ADORA1
SCHEMBL25679990 0.85 PRMT6 (0.45) PRMT6P2RY12ADORA1
SCHEMBL19146295 0.84 PRMT6 (0.38) PRMT6P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3922637-A1 MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES Janssen Pharmaceutica NV (BE) 2021-12-15 EP disclosed
WO-2019175260-A2 MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE IN TAUOPATHIES JANSSEN PHARMACEUTICA NV (BE) 2019-09-19 WO disclosed